user
menu
letter
Sign InRegister
langEnglisharrow

CD6

CD6

CD6 詳細

Molecule Name
T-cell differentiation antigen CD6
分子の別称
CD6,TP120,T12
Drug Development Progress
治験薬の数1
市販薬剤の数1
研究＆開発段階Approved
ターゲットの別称
T12，CD6，CD6 Molecule，TP120，T-Cell Differentiation Antigen CD6，CD6 Antigen
バックグランド
CD6 (Cluster of Differentiation 6) is a transmembrane protein primarily expressed on T-lymphocytes and certain other immune cells. Structurally, it is characterized by three scavenger receptor cysteine-rich (SRCR) domains and a binding site for an activated leukocyte cell adhesion molecule (ALCAM). Functionally, CD6 is critical for the continuation of T cell activation and exhibits scavenger receptor activity. Aberrant CD6 function is associated with diseases such as Multiple Sclerosis. Its paralog is DMBT1.

CD6 製品リスト

Species
  • Cynomolgus（3）
  • Human（3）
Tag
  • Fc Tag & Avi Tag（2）
  • His Tag（2）
  • His Tag & Avi Tag（2）
Host
  • HEK293（6）
Conjugate
  • Biotin-labeled（4）
  • Unconjugated（2）
Grade
  • RUO（6）
Low Endotoxin
  • No（6）
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
CD6
HOTAvitag
CD6-H82E3
Biotinylated Human CD6 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
HOT
CD6-H52H7
Human CD6 / TP120 Protein, His Tag
Human
HEK293
SDS-PAGE

$340.00

100ug
CD6
CD6-C52H3
Cynomolgus CD6 Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$395.00

100ug
CD6
Avitag
CD6-C82E3
Biotinylated Cynomolgus CD6 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Avitag
CD6-C82F3
Biotinylated Cynomolgus CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Avitag
CD6-H82F3
Biotinylated Human CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

お問い合わせRequest Customization
Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells therapy (City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Diabetes Mellitus, Type 1; Graft vs Host Disease; Hemic and Lymphatic Diseases
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600; Bmab600ApprovedCenter Of Molecular ImmunologyAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01
Asthma; Coronavirus Disease 2019 (COVID-19); Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Plaque psoriasis; Psoriasis; Respiratory Distress Syndrome, Adult
詳細
Customer Reviews
  • g***t2025-11-28
    Human CD6 / TP120 Protein, His Tag
    We use Human CD16 from AcroBiosystems since many years now for in vitro characterization of antibodies and we are very happy to have well documented certificate to set up our experiments.